5 Best Biotech ETFs To Buy

Page 1 of 5

In this article, we discuss 5 best biotech ETFs to buy. If you want to read our discussion on the biotech industry, head directly to 11 Best Biotech ETFs To Buy

5. Virtus LifeSci Biotech Products ETF (NYSE:BBP)

5-Year Share Price Performance as of April 2: 21.63%

Virtus LifeSci Biotech Products ETF (NYSE:BBP) aims to mirror the performance of the LifeSci Biotechnology Products Index, which monitors biotechnology firms with at least one FDA-approved drug therapy, before accounting for fees and expenses. As of April 1, 2024, the fund owns $19.7 million in net assets, with an expense ratio of 0.79%. It is one of the best biotech ETFs to monitor. 

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is the largest holding of Virtus LifeSci Biotech Products ETF (NYSE:BBP). Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is an American biopharmaceutical company that specializes in developing and commercializing innovative treatments for eye care. On February 27, the company reported a Q4 GAAP EPS of -$1.31 and a revenue of $13.08 million, exceeding Wall Street estimates by $0.01 and $7.16 million, respectively. 

According to Insider Monkey’s fourth quarter database, 18 hedge funds were long Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), compared to 20 funds in the earlier quarter. 

Follow Tarsus Pharmaceuticals Inc.

Page 1 of 5